Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis-Reference-Cited by-同舟云学术

Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis

Published:2021-07-26 Issue:12 Volume:61 Page:1567-1578
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Cho Yong‐Soon¹²^ORCID,Jang Tae Won³,Kim Hyo‐Jung⁴,Oh Jee Youn⁵,Lee Hyun‐Kyung¹⁶,Park Hye Kyeong⁷,Ghim Jong‐Lyul¹²,Long Nguyen Phuoc¹,Park Yumi¹,Choi Young‐Kyung¹,Phuong Nguyen Thi Thu⁸^ORCID,Shin Jae‐Gook¹²,

Affiliation:

1. Center for Personalized Precision Medicine of Tuberculosis (cPMTb) Inje University College of Medicine Busan Republic of Korea

2. Department of Pharmacology and Clinical Pharmacology PharmacoGenomics Research Center Inje University College of Medicine Busan 47392 Republic of Korea

3. Department of Pulmonology Kosin University Gospel Hospital Kosin University College of Medicine Busan Republic of Korea

4. Division of Pulmonology and Critical Care Medicine Department of Internal Medicine Inje University Haeundae Paik Hospital Busan Republic of Korea

5. Division of Pulmonary Allergy and Critical Care Medicine Department of Internal Medicine Korea University Guro Hospital Seoul Republic of Korea

6. Division of Pulmonary Allergy and Critical Care Medicine Department of Internal Medicine Busan Paik Hospital Inje University College of Medicine Busan Republic of Korea

7. Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Ilsan Paik Hospital Inje University College of Medicine Busan Republic of Korea

8. Faculty of Pharmacy Hai Phong University of Medicine and Pharmacy Haiphong Vietnam

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1931

Reference51 articles.

1. Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis

2. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis

3. The early bactericidal activity of drugs in patients with pulmonary tuberculosis;Jindani A;Am Rev Respir Dis,1980

4. Bactericidal and Sterilizing Activities of Antituberculosis Drugs during the First 14 Days

5. WHO guidelines for treatment of tuberculosis: the missing links

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-17

2. Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis;Clinical Pharmacokinetics;2024-07

3. Model‐based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis;British Journal of Clinical Pharmacology;2024-04-03

4. Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository;Drug Design, Development and Therapy;2024-03

5. Application of the Hollow-Fiber Infection Model to Personalized Precision Dosing of Isoniazid in a Clinical Setting;Journal of Korean Medical Science;2024